findmyKOL
Clinical trialNCT07695311Not, yet, recruitingPhase 1Interventional

EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT

SponsorRabi HannaEnrollment24Desmoplastic Small Round Cell TumorEwing Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Matteo Trucco, MD

    Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute

    Principal Investigator
  • Peter M Anderson, MD, PhD

    Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute

    Principal Investigator
  • Rabi Hanna, MD

    Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute

    Principal Investigator
  • Timothy A Chan, MD, PhD

    Case Comprehensive Cancer Center, Cleveland Clinic Center for Immunotherapy and Immuno-Oncology

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute

    Cleveland, Ohio, United States

    Matteo Trucco, MDPeter M Anderson, MD, PhDRabi Hanna, MDTimothy A Chan, MD, PhD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2026
Primary completion
31 Oct 2029
Completion
31 Jul 2030
Last update posted
10 Jul 2026
Registered enrollment
24
Registry id
NCT07695311

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.